Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Żarów

11 clinical trials in Żarów, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Żarów at a glance
11
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

11 trials in Żarów

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Cardiac failure

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Atrial fibrillation

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Atrial fibrillation

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Żarów

What the registry says about research in the country

01 Cardiovascular Research

Clinical trials focusing on atrial fibrillation management, evaluating new therapeutic approaches for preventing stroke and managing irregular heart rhythms. Research includes comparative studies of novel anticoagulation treatments.

  • Irregular Heart Rhythm Management
  • Stroke Prevention
  • Blood Clot Prevention

Multiple studies are exploring innovative medications to improve patient outcomes in cardiac care.

02 Metabolic Disorders

Groundbreaking research targeting hypertriglyceridemia, investigating new treatments to help patients manage elevated triglyceride levels in both moderate and severe cases.

  • Lipid Management
  • Triglyceride Reduction
  • Metabolic Health

Studies aim to evaluate novel therapeutic approaches for controlling blood lipid levels.

03 Heart Failure Studies

Innovative clinical research examining combination therapies for heart failure, with a focus on improving outcomes for patients with reduced ejection fraction.

  • Cardiac Function
  • Combination Therapy
  • Cardiovascular Mortality

Research focuses on testing novel drug combinations to enhance heart failure treatment efficacy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.